Back
USCB Financial Holdings, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
67
USCB
USCB Financial Holdings, Inc.
Last Price:
$19.04
Seasonality Move:
-4.59%
Buy
63
GPCR
Structure Therapeutics, Inc.
Last Price:
$69.34
Seasonality Move:
-34.19%
Buy
67
USCB Financial Holdings, Inc. (USCB)
is a Buy
Is USCB Financial Holdings, Inc. a Buy, Sell or Hold?
-
The current USCB Financial Holdings, Inc. [USCB] share price is $19.04. The Score for USCB is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
USCB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
USCB Stock Price Chart
What is USCB Financial Holdings, Inc.'s stock price today?
-
The USCB Financial Holdings, Inc. share price today is $19.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USCB is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $71.29Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
USCB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.75 | Buy |
| Relative Strength Index (14 RSI): | 58.03 | Buy |
| Chaikin Money Flow: | -13708 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.75 - 19.17) | Buy |
| Bollinger Bands (100): | (16.8 - 18.26) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.5 | Buy |
| Relative Strength Index (14 RSI): | 72.85 | Buy |
| Chaikin Money Flow: | 1903413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.41 - 65.27) | Buy |
| Bollinger Bands (100): | (17 - 45.24) | Buy |
USCB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.37 | Sell |
| 20-day SMA: | 18.65 | Buy |
| 50-day SMA: | 17.94 | Buy |
| 200-day SMA: | 17.35 | Buy |
| 8-day EMA: | 13.79 | Buy |
| 20-day EMA: | 7.61 | Buy |
| 50-day EMA: | 3.51 | Buy |
| 200-day EMA: | 0.94 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.43 | Buy |
| 20-day SMA: | 52.92 | Buy |
| 50-day SMA: | 40.28 | Buy |
| 200-day SMA: | 26.09 | Buy |
| 8-day EMA: | 64 | Buy |
| 20-day EMA: | 55.88 | Buy |
| 50-day EMA: | 44.22 | Buy |
| 200-day EMA: | 31.26 | Buy |
USCB Financial Holdings, Inc. Earnings Growth & USCB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $0.44 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.
USCB Financial Holdings, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||